Integrated Research Limited provided revenue guidance for the full year 2023. Subject to audit, the company expected the TCV result to translate into reported statutory revenue in the range of $39 million - $42 million for the period, an increase of 1% - 9% on the pcp. On a pro-forma basis, revenue is anticipated to be in the range of $36 million - $38 million, down -6% - 0% on the pcp, reflecting lower recurring (licence) revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.785 AUD | -0.63% | +86.90% | +118.06% |
05-10 | Integrated Research's Shares Surge More Than 50% on Upbeat Guidance | MT |
03-06 | Cathy Aston Resigns as Director of Integrated Research Limited, Effective 31 March 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.06% | 91.34M | |
+12.15% | 3,096B | |
+12.62% | 85.37B | |
+7.02% | 77.1B | |
-13.71% | 54.31B | |
-22.61% | 47.92B | |
+25.45% | 47.74B | |
+19.87% | 42.15B | |
+69.53% | 38.06B | |
-8.94% | 24.73B |
- Stock Market
- Equities
- IRI Stock
- News Integrated Research Limited
- Integrated Research Limited Provides Revenue Guidance for the Full Year 2023